PHPS1 sodium is a potent and selective Shp2 inhibitor used for:
- Inhibiting proliferation of human tumor cells (e.g., MDA-MB-435, HCT-116, HCT-15, PC-3, HT-29, NCI-H661, and Caki-1) in vitro;
- Suppressing HGF/SF-induced Erk1/2 phosphorylation and activation in a dose- and time-dependent manner without affecting Akt or Stat3 phosphorylation;
- Reducing atherosclerotic plaque size in Ldlr−/− mice when administered intraperitoneally (3 mg/kg daily during the last week of a high-fat diet), thereby attenuating atherosclerosis development.